🇨🇦 Desvenlafaxine Succinate Sustained-Release Formulation 50 mg in Canada

Desvenlafaxine Succinate Sustained-Release Formulation 50 mg (Desvenlafaxine Succinate Sustained-Release Formulation 50 mg) regulatory status in Canada.

Marketing authorisation

Desvenlafaxine Succinate Sustained-Release Formulation 50 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Desvenlafaxine Succinate Sustained-Release Formulation 50 mg approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Desvenlafaxine Succinate Sustained-Release Formulation 50 mg in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.